chromium has been researched along with Arteriosclerosis, Coronary in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.13) | 18.2507 |
| 2000's | 3 (7.69) | 29.6817 |
| 2010's | 31 (79.49) | 24.3611 |
| 2020's | 3 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, R; Barragan, P; Bressollette, E; Chun-Chin, C; Hanratty, CG; Kretov, E; Lesiak, M; McEntegart, MB; Menown, I; Merkulov, E; O'Kane, P; Oldroyd, KG; Onuma, Y; Peace, A; Protopopov, A; Rocchiccioli, P; Silvestri, M; van Geuns, RJ; Wlodarczak, A | 1 |
| Asano, T; Chichareon, P; Digne, F; Gil, RJ; Kogame, N; Lefèvre, T; Legutko, J; Modolo, R; Morel, MA; Onuma, Y; Serruys, PW | 1 |
| Hayashi, T; Hibi, K; Ishida, M; Ito, Y; Itoh, T; Kikuchi, T; Morino, Y; Morita, T; Okamura, T; Otake, H; Sawada, T; Shinke, T; Shite, J; Suzuki, T; Takahashi, F; Terashita, D; Tsukiyama, Y | 1 |
| Danielewicz, M; Hambraeus, K; James, S; Lagerqvist, B; Lindholm, D; Olivecrona, G; Råmunddal, T; Sarno, G; Varenhorst, C; Witt, N | 1 |
| Allocco, DJ; Chen, J; Dawkins, KD; Fu, G; Han, Y; Hong, T; Jiang, T; Li, H; Liu, H; Pang, W; Su, X; Sun, F; Wang, H; Xu, K; Yang, Y; Yuan, Z; Zhang, J; Zhang, M | 1 |
| Aizawa, Y; Fujita, S; Fuse, K; Hatada, K; Ikeda, Y; Kishi, S; Matsubara, T; Okabe, M; Sato, T; Takahashi, M | 1 |
| Chong, AY; Di Santo, P; Dwivedi, G; Glover, C; Hibbert, B; Jung, RG; Motazedian, P; Ramirez, FD; Simard, T | 1 |
| Aoki, J; Awata, M; Kimura, T; Kozuma, K; Kusano, H; Nanasato, M; Nie, H; Shiode, N; Tanabe, K; Yamaguchi, J | 1 |
| Anderson, R; Asano, T; Baumbach, A; Johnson, T; Kiemeneij, F; Lansky, AJ; Onuma, Y; Serruys, PW; Slagboom, T; Van Royen, N; Vlachojannis, G; Wijns, W; Xu, B; Zheng, M | 1 |
| Abayaweera, G; Abou-Taleb, HA; AbouElhassan, KM; AbouTaleb, HA; Adair, LS; Adams, E; Addison, O; Addy, I; Akhtar, N; Alten, B; Anesini, J; Añez, R; Angaridis, PA; Aouba, A; Arakawa, K; Aumeeruddy-Elalfi, Z; Bao, LP; Basu, E; Bayraktar, E; Bekkelund, CS; Bell, J; Beraldo, H; Bermúdez, V; Betenbaugh, MJ; Bhattacharya, R; Bienvenu, B; Bolzoni, M; Bootz, F; Borja, JB; Bove, DG; Bowden, ME; Bradsher, C; Brockstedt, D; Brothers, RM; Buschauer, A; Calandriello, L; Caporossi, A; Carba, DB; Carratalà, J; Castella, B; Caviezel, D; Ceccato, R; Charalambidis, G; Charisiadis, A; Chattopadhyay, P; Chen, Q; Chen, W; Chen, Y; Chen, YT; Chen, ZJ; Chen, ZY; Cheng, MA; Cheng, ZB; Cherevko, S; Cheung, IY; Cheung, NV; Chiappini, A; Chiu, YL; Choi, IG; Chough, S; Chung, CY; Cobb, A; Colotto, A; Continentino, MA; Cook, AJMC; Costa, F; Coutsolelos, AG; Cuperus, N; Curtis, BM; Davenport, AJ; de Boysson, H; Dela, F; Deng, XP; Deshayes, S; Dhara, K; Dietrich, D; Dietrich, J; Dilhari, A; Ding, R; Ding, Y; Dirè, S; Dohlmann, TL; Dotsenko, A; Doubrovina, E; Du, K; Du, ZJ; Duvic, M; Eastman, A; Eliakim-Raz, N; Elz, S; Emile, JF; Emmerling, C; Engelhard, MH; Eriksson, JG; Etzold, BJM; Faini, AC; Falsini, B; Farmer, E; Fei, JJ; Ferreira, IP; Föttinger, K; Franconieri, F; Fryda, NJ; Fuentes, I; Galateau-Sallé, F; Ganguly, M; Gani, BA; Gao, X; Gao, XF; Gao, XJ; García-Mendiola, T; Garg, A; Gascon, J; Gayani, B; Gevensleben, H; Gilbert, M; Giudiceandrea, A; Giuliani, N; Gocmen, AY; Goldman, DA; Goltz, D; Gombert, AK; Gomila, A; Goodwin, P; Górnicki, K; Gostin, PF; Graterol, M; Gremillet, C; Grier, S; Grün, AL; Gusakov, A; Halldórsdóttir, HR; Han, L; Han, Z; Hävecker, M; Helge, JW; Heo, K; Hernández, JD; Hindsø, M; Holmen Olofsson, G; Hong, CE; Hong, J; Horenstein, AL; Hosenally, M; Hruz, P; Hsu, HL; Hsu, KC; Hu, SF; Hu, Y; Huang, K; Huang, S; Huang, WH; Humaira, A; Hung, CF; Hung, WS; Huo, XK; Huvinen, E; Idorn, M; Ignatyev, K; Im, WT; Ismaël, IS; Jakobsson, JG; Janaszek-Mańkowska, M; Jeong, GT; Ji, L; Ji, X; Jiang, Y; Jo, IH; Jo, SH; Johnson, AC; Johnson, LE; Kadirvelu, K; Kahnt, A; Kaleta, A; Kamiya, T; Kang, DH; Kang, XH; Kashiwagi, T; Katayama, E; Kawachi, N; Keller, M; Kellermann, L; Khan, T; Khan, ZA; Kharshoum, RM; Khim, JS; Kikuchi, M; Kim, BS; Kim, DS; Kim, DW; Kim, JH; Kim, JJ; Kim, JU; Kim, SK; Kim, WS; Kimura, J; Kiss, C; Knop-Gericke, A; Kobayashi, S; Koivusalo, SB; Kolar, E; Kottegoda, N; Kramer, K; Kristiansen, G; Kruger, AA; Kumar, S; Kumar, V; Kumarage, S; Kursungoz, C; Kushner, BH; Kuwahara, F; Kuzawa, C; Kwon, BO; Landsberg, J; Larsen, S; Lauer, P; Le Luduec, JB; Lee, DW; Lee, H; Lee, HY; Lee, JW; Lee, MJ; Lee, SW; Lefrançois, P; Leibovici, L; Leong, KK; Leong, M; Li, B; Li, D; Li, G; Li, J; Li, YZ; Liang, JH; Liang, X; Liens, A; Ligorio, G; Lin, JD; Lindholm, MG; Liou, MJ; List-Kratochvil, EJW; Litvinov, IV; Liu, F; Liu, S; Liu, Y; Liu, Z; Lohar, S; Lopes, MTP; Lorenzo, E; Lu, X; Lukashuk, L; Lukens, WL; Luo, HR; Luo, L; Luttik, MAH; Ma, Y; MacGowan, A; Mahomoodally, MF; Maissen, S; Malavasi, F; Malhotra, M; Mallik, S; Manna, D; Mans, R; Marangoni, D; Marimpietri, D; Marques, F; Marques, WL; Marsaa, K; Martin Silva, N; Martinez, A; Martínez, MS; Massaia, M; Mayrhofer, KJJ; McDade, T; McNeel, DG; Met, Ö; Micalizio, GC; Modak, S; Morandi, F; Moreau, L; Morla, S; Morrell, AP; Morris, S; Mubarak, Z; Muchlisin, ZA; Munoz, M; Nagao, Y; Nakama, T; Nakamura, H; Nakano, T; Nardi, MV; Nasirian, A; Nelson, MD; Netchiporouk, E; Ni, X; Niess, JH; Nijenhuis, JM; Nikolaou, V; O'Connor, BJ; O'Reilly, RJ; Odobel, F; Ohata, C; Ohyama, B; Olivar, LC; Ordoñez, MG; Ostrovnaya, I; Palmar, J; Panda, S; Pandiyarajan, S; Park, B; Park, H; Park, JH; Park, S; Pasquali, L; Patik, JC; Pearce, CI; Peele, ME; Peng, S; Perera, IC; Petty, JT; Pidko, EA; Pinheiro, CB; Pistoia, V; Pita, M; Planchat, A; Plass, F; Pockes, S; Pradhan, N; Premasudha, P; Pronk, JT; Provost, N; Pujol, M; Qi, P; Qiu, J; Qiu, Z; Quan, J; Quaranta, A; Ra, CH; Rameshan, R; Ranglack, DH; Rausch-Fan, X; Rieger, E; Rivas, JR; Roberts, SS; Rocha, WR; Rodrigues, GLS; Rojas, J; Roy, P; Rozhkova, A; Rufo, S; Rupprechter, G; Saeui, CT; Saha, A; Sakai, M; Salazar, J; Salem, HF; Salgarello, T; Samarakoon, SR; Sandau, C; Sandbeck, DJS; Santos, AF; Santos, VG; Sara, Y; Saslow, SA; Sasseville, D; Sato, S; Sauer, JD; Schlögl, R; Schweiger, MJ; Shashkov, I; Shaw, E; Shen, WQ; Shim, J; Shu, J; Singh, C; Sinha Babu, SP; Sinitsyn, A; Sinitsyna, O; Skadborg, SK; Song, Q; Song, W; Stach-Lempinen, B; Stoddart, M; Stoica, M; Street, SR; Sukwong, P; Sun, CP; Sun, J; Sunwoo, IY; Suresh, S; Szécsényi, Á; Takahashi, T; Takeda, S; Tang, D; Tas, ST; Tebé, C; Teixeira, LR; Teixidor, F; Terrier, B; Teschner, D; Tetzlaff, MT; Theisen, E; Thor Straten, P; Tiitinen, A; Timpel, M; Toccoli, T; Torikai, K; Torres, W; Toscani, D; Trad, S; Tsai, HJ; Tseng, CP; Tucker, WJ; Um, W; Vallejo-Torres, L; van den Broek, M; Van den Heuvel, L; van der Woude, LN; van Maris, AJA; Van Schepdael, A; Vank, C; Verucchi, R; Vigo, JM; Viñas, C; Vogt, TJ; Vuong, C; Wai, H; Wang, B; Wang, D; Wang, H; Wang, JJ; Wang, K; Wang, L; Wang, Q; Wang, YR; Watanabe, S; Watters, AK; Weerasekera, MM; Wei, L; Wheeler, DA; Wiegand, I; Wifling, D; Wijesinghe, GK; Winiczenko, R; Wolker, T; Wu, J; Wu, TC; Wu, YY; Xie, P; Xie, YP; Xu, A; Xu, E; Xu, L; Xu, Z; Yamaguchi, M; Yang, A; Yang, G; Yang, J; Yang, TM; Yang, W; Yang, Y; Yarema, KJ; Yesiltepe, M; Yi, KJ; Yigit, N; Yim, UH; Yin, B; Yu, S; Zengin, G; Zhang, B; Zhang, C; Zhang, GR; Zhang, H; Zhang, J; Zhang, L; Zhang, TY; Zhang, X; Zhang, Y; Zhang, YX; Zhao, H; Zhao, JC; Zhao, Z; Zheng, R; Zhou, W; Zorn Morales, N | 1 |
| Allocco, DJ; Christen, T; Crowley, J; Ferrario, M; Jung, W; Legrand, V; MacCarthy, P; Meredith, IT; Moreno, R; Redwood, S; Richardt, G; Schwimmbeck, P; Ungi, I; Werner, N; Zaman, A | 1 |
| Cannon, LA; Dawkins, KD; Grady, TP; Hill, R; Kimmelstiel, CD; Myers, PR; Underwood, P; White, A | 1 |
| Allocco, D; Aquino, M; Batchelor, W; Claessen, BE; Davis, S; Gigliotti, OS; Giugliano, G; Guedeney, P; Haghighat, A; Horwitz, PA; Kandzari, DE; Lopez, M; Mehran, R; Meredith, IT; Othman, I; Singh, S; Sorrentino, S; Tamis, L; Underwood, P; Wang, JC | 1 |
| Fujii, K; Fujimoto, Y; Himi, T; Ishikawa, K; Kadohira, T; Kitahara, H; Kobayashi, Y; Oka, N; Sano, K; Takahara, M | 1 |
| Allocco, DJ; Amjadi, N; Caputo, C; Chen, H; Kandzari, DE; Meredith, IT; Rowe, SK; Tamboli, HP; Underwood, PL; Williams, J | 1 |
| Ariza, A; Cequier, A; de Albert, M; Ferreiro, JL; Gomez-Hospital, JA; Gomez-Lara, J; Gracida, M; Romaguera, R; Roura, G; Teruel, L | 1 |
| Allocco, DJ; Cannon, LA; Dawkins, KD; Dens, J; Dubois, CL; Feldman, RL; Lee, TC; Meredith, IT; Mooney, MR; Pompili, VJ; Rabinowitz, AC; Saito, S; Stone, GW; Teirstein, PS | 1 |
| Agostoni, P; Bolognese, L; Bongo, AS; De Maria, GL; Fattori, R; Lazzero, M; Lupi, A; Parisi, R; Porto, I; Rognoni, A; Secco, GG; Sheiban, I | 1 |
| Beleslin, B; Carrie, D; Danzi, GB; Iniguez, A; Macaya, C; Mehmedbegovic, Z; Moreno, R; Putnikovic, B; Schächinger, V; Zeymer, U | 1 |
| Brugaletta, S; Cequier, A; de Belder, A; de la Torre Hernandez, JM; Eberli, F; Ferrante, G; Galatius, S; Kaiser, C; Sabaté, M; Serruys, PW; Valgimigli, M | 1 |
| Abbott, JD; Srour, JF | 1 |
| Allocco, DJ; Dawkins, KD; Fang, Q; Gao, R; Han, Y; Hou, Y; Li, H; Wang, H; Xu, B; Yang, Y; Yu, B; Zhang, J | 1 |
| Chan, KH; Chan, M; Fang, WY; Lee, CH; Li, RG; Low, A; Qu, XK; Richards, AM; Tan, HC | 1 |
| Hu, ZY; Iqbal, J; Pan, DR; Pang, S; Tian, NL; Wu, W; Xu, B; Zhang, YJ; Zhu, H | 1 |
| Ando, K; Domei, T; Enomoto, S; Hiromasa, T; Hyodo, M; Iwabuchi, M; Kuramitsu, S; Mazaki, T; Shinozaki, T; Shirai, S; Soga, Y; Yamaji, K | 1 |
| Allocco, DJ; Amjadi, N; Caputo, C; Christen, T; Dawkins, KD; Kandzari, DE; Rowe, SK; Tamboli, HP; Williams, J | 1 |
| Ge, J; Ge, L; Qian, J; Yang, J; Zhang, F; Zhou, J | 1 |
| Fraccaro, C; Grossi, P; Mariani, L; Moretti, L; Silenzi, S; Vagnarelli, F | 1 |
| Hirohata, A; Kataoka, K; Kimura, T; Kozuma, K; Morino, Y; Tanabe, K; Tobaru, T; Yasuda, S | 1 |
| Arana, C; Dager, A; Delgado, JA; Gasior, P; Généreux, P; Granada, JF; Hernandez, H; Higuera, S; Maehara, A; Moncada, M; Vesga, B | 1 |
| Byrne, RA; Cassese, S; Colleran, R; de Waha, A; Fusaro, M; Giacoppo, D; Harada, Y; Kastrati, A; Kufner, S; Laugwitz, KL; Ndrepepa, G; Rheude, T; Schunkert, H; Xhepa, E | 1 |
| Asano, T; de Winter, RJ; Dijkstra, J; Jonker, H; Katagiri, Y; Kimura, T; Kozuma, K; Miyazaki, Y; Onuma, Y; Popma, JJ; Serruys, PW; Sotomi, Y; Stone, GW; Tanabe, K; Tenekecioglu, E; Wykrzykowska, JJ | 1 |
| Ahmed, WH; Al-Ama, N; Alissa, EM; Bahjri, SM; Ferns, GA | 1 |
| Agostoni, P; Belkacemi, A; Doevendans, PA; Samim, M; Stella, PR; Voskuil, M | 1 |
| Büttner, HJ; Gick, M; Leibundgut, G; Löffelhardt, N; Neumann, FJ; Toma, A; Valina, C | 1 |
| Buszman, P; Kinasz, L; Kondys, M; Król, M; Milewski, K; Trznadel, S; Zurakowski, A | 1 |
| Baffour, R; Hellinga, D; Pakala, R; Seabron, R; Tio, FO; Waksman, R | 1 |
| Chambless, LE; Roeback, JR | 1 |
| Abraham, AS; Balkin, J; Ilan, M; Klutstein, M; Rosenmann, D; Zion, MM | 1 |
2 review(s) available for chromium and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis.
Topics: Chromium; Cobalt; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Sirolimus; Stents; Thrombosis; Treatment Outcome | 2014 |
Cobalt chromium-based biodegradable polymer sirolimus-eluting stent: rationale, evidence and clinical experience.
Topics: Chromium; Cobalt; Coronary Artery Disease; Drug Liberation; Drug-Eluting Stents; Humans; Percutaneous Coronary Intervention; Polymers; Prosthesis Design; Sirolimus; Thrombosis | 2015 |
11 trial(s) available for chromium and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial.
Topics: Absorbable Implants; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platinum; Polymers; Treatment Outcome | 2022 |
Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study.
Topics: Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Humans; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Treatment Outcome | 2020 |
A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study.
Topics: Adolescent; Adult; Aged; China; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Polymers; Sirolimus; Treatment Outcome; Young Adult | 2017 |
Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the Firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic le
Topics: Atherosclerosis; Chromium; Cobalt; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Europe; Humans; Neointima; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Tomography, Optical Coherence; Treatment Outcome | 2018 |
Topics: Activities of Daily Living; Acute Disease; Adalimumab; Adaptation, Physiological; Adenosine Triphosphate; Adipose Tissue; Administration, Intravaginal; Adolescent; Adsorption; Adult; Adverse Childhood Experiences; Age Distribution; Age Factors; Aged; Aged, 80 and over; Air Pollution, Indoor; Aldehyde Oxidase; Alginates; Alloys; alpha-Globins; Aluminum Hydroxide; Alveolar Bone Loss; Anaerobiosis; Anesthesia, General; Anesthetics; Animals; Anovulation; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Bacillus cereus; Bacterial Typing Techniques; Bacteroidetes; Base Composition; Biocompatible Materials; Biofilms; Biological Availability; Biological Transport; Biosensing Techniques; Bipolar Disorder; Blood Glucose; Body Mass Index; Bone Regeneration; Boranes; Brachial Artery; Butyric Acid; Candida albicans; Carbon; Carcinoembryonic Antigen; Cell Differentiation; Cell Line, Tumor; Cell Respiration; Cell Survival; Cells, Cultured; Cerebrovascular Circulation; Charcoal; Child; Child Health; China; Chloride Channels; Chlorides; CHO Cells; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromium; Chronic Disease; Chronic Periodontitis; Circular Dichroism; Cities; Cohort Studies; Comamonadaceae; Comorbidity; Coronary Artery Disease; Corrosion; Cricetinae; Cricetulus; Cross Infection; Cross-Sectional Studies; Crowding; Culture Media; Cytokines; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diarylheptanoids; Diclofenac; Disability Evaluation; Diterpene Alkaloids; DNA; DNA Mutational Analysis; DNA, Bacterial; Drug Liberation; Drug Resistance, Multiple, Bacterial; Electrochemical Techniques; Electrodes; Electrolytes; Endothelium, Vascular; Enterococcus faecalis; Epithelial Cell Adhesion Molecule; Epithelial Cells; Erbium; Erythropoietin; Ethanol; Ethylenediamines; Fast Foods; Fatty Acids; Female; Fermentation; Ferric Compounds; Fibroblasts; Flavobacteriaceae; Fluorides; Fluorodeoxyglucose F18; Food Microbiology; Formaldehyde; Furaldehyde; Gamma Cameras; Gene Expression; Geologic Sediments; Glucose Tolerance Test; Glycated Hemoglobin; Glycolipids; Glycosylation; Gracilaria; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Guanine; Health Surveys; HeLa Cells; Hemoglobins, Abnormal; Hexosamines; High Fructose Corn Syrup; High-Intensity Interval Training; Hip Fractures; Hippocampus; HLA-B27 Antigen; Hospitalization; Housing; Humans; Hydrogen-Ion Concentration; Hydrolysis; Hydroxides; Hypercapnia; Hypertension; Hypocreales; Hypromellose Derivatives; Image Processing, Computer-Assisted; Incidence; Indole Alkaloids; Indonesia; Inflammation Mediators; Infrared Rays; Insulin Resistance; Intercalating Agents; Ion Transport; Ionophores; Japan; Kinetics; Kluyveromyces; Letrozole; Linear Models; Lipopolysaccharides; Liposomes; Liver; Lung Diseases; Magnesium Hydroxide; Magnetic Resonance Spectroscopy; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Middle Aged; Mitochondria; Mitochondria, Muscle; Molecular Docking Simulation; Molecular Structure; Muscle, Skeletal; Mutant Proteins; Mutation; Mutation, Missense; Nanocomposites; Nanoparticles; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Nucleic Acid Hybridization; Obesity; Occupational Exposure; Oceans and Seas; Odds Ratio; Organometallic Compounds; Osteogenesis; Ovulation Induction; Oxidation-Reduction; Particle Size; Periodontal Ligament; Permeability; Phaseolus; Phenotype; Philippines; Phosphatidylethanolamines; Phospholipids; Photochemical Processes; Phylogeny; Pichia; Pigmentation; Plant Extracts; Polycystic Ovary Syndrome; Polysaccharides; Postprandial Period; Pregnancy; Pregnancy Rate; Prevalence; Product Surveillance, Postmarketing; Progesterone; Progestins; Protein Engineering; Pseudomonas aeruginosa; Psoriasis; Public Facilities; Rats; Rats, Wistar; Receptors, Thyrotropin; Recombinant Proteins; Reproducibility of Results; Republic of Korea; Retrospective Studies; Rhodobacteraceae; Risk; Risk Assessment; Risk Factors; RNA, Ribosomal, 16S; ROC Curve; Saccharomyces cerevisiae; Salinity; Saliva; Seawater; Seaweed; Sensitivity and Specificity; Sequence Analysis, DNA; Sex Factors; Silver Compounds; Smokers; Social Class; Socioeconomic Factors; Soil Microbiology; Solubility; Soy Foods; Spectrometry, Mass, Electrospray Ionization; Spondylitis, Ankylosing; Staphylococcus aureus; Static Electricity; Steroids; Strontium; Sucrose; Surface Properties; Survival Rate; Sweden; Swine; Synapses; Synchrotrons; Tandem Mass Spectrometry; Tannins; Tea; Temperature; Terpenes; Thalidomide; Thermodynamics; Thiadiazoles; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tissue Distribution; Titanium; Toilet Facilities; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ubiquinone; Urinary Tract Infections; Vaginal Creams, Foams, and Jellies; Venezuela; Vitamin K 2; Waist Circumference; Waste Disposal, Fluid; Wastewater; Water Microbiology; Water Pollutants, Chemical; Whole Body Imaging; X-Ray Diffraction; Young Adult; Ytterbium; Yttrium; Yttrium Radioisotopes; Zinc Compounds | 2018 |
Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions.
Topics: Aged; Cardiovascular Agents; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; Japan; Male; Middle Aged; New Zealand; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Design; Sirolimus; Time Factors; Treatment Outcome; United States | 2015 |
Cobalt-chromium KAname™ coRonary stEnt system in the treatment of patients with coronary artery disease (KARE study).
Topics: Aged; Angioplasty, Balloon, Coronary; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; France; Humans; Hyperplasia; Male; Middle Aged; Neointima; Prospective Studies; Stents | 2014 |
PLATINUM China: a prospective, randomized investigation of the platinum chromium everolimus-eluting stent in de novo coronary artery lesions.
Topics: Adult; Aged; Cardiovascular Agents; China; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platinum; Prospective Studies; Prosthesis Design; Single-Blind Method; Time Factors; Treatment Outcome | 2015 |
Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials.
Topics: Aged; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Polymers; Treatment Outcome | 2017 |
Methods for assessing difference between groups in change when initial measurements is subject to intra-individual variation.
Topics: Adrenergic beta-Antagonists; Apolipoprotein A-I; Bias; Black People; Cholesterol, HDL; Chromium; Clinical Trials as Topic; Coronary Artery Disease; Data Interpretation, Statistical; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Models, Statistical; White People | 1993 |
Progression and regression of coronary artery disease in one year. Quantitative angiographic assessment in patients with stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Chromium; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Remission, Spontaneous | 1993 |
26 other study(ies) available for chromium and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Vascular Response Occurring at 3 Months After Everolimus-Eluting Cobalt-Chromium Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction vs. Stable Coronary Artery Disease.
Topics: Chromium; Cobalt; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Percutaneous Coronary Intervention; Prospective Studies; ST Elevation Myocardial Infarction; Thrombosis; Tomography, Optical Coherence; Treatment Outcome | 2020 |
Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
Topics: Absorbable Implants; Aged; Angioplasty, Balloon, Coronary; Chromium; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Platinum; Polymers; Postoperative Complications; Proportional Hazards Models; Prosthesis Design; Registries; Retrospective Studies; Survival Rate; Sweden; Time Factors; Treatment Outcome | 2017 |
Comparison of clinical outcomes of coronary artery stent implantation in patients with end-stage chronic kidney disease including hemodialysis for three everolimus eluting (EES) stent designs: Bioresorbable polymer-EES, platinum chromium-EES, and cobalt c
Topics: Absorbable Implants; Aged; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Renal Dialysis; Risk Factors; Trace Elements; Treatment Outcome | 2018 |
Evaluation of Cobalt and Chromium Levels Following Implantation of Cobalt Chromium Coronary Stents: A Pilot Study.
Topics: Biomarkers; Chromium; Chromium Alloys; Cobalt; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pilot Projects | 2018 |
Five-year clinical outcomes of everolimus-eluting stents from the post marketing study of CoCr-EES (XIENCE V/PROMUS) in Japan.
Topics: Aged; Chromium; Cobalt; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Percutaneous Coronary Intervention; Product Surveillance, Postmarketing; Prospective Studies; Prosthesis Design; Registries; Survival Analysis; Treatment Outcome | 2019 |
Clinical outcomes in unselected patients treated with the PROMUS Element platinum-chromium, everolimus-eluting stent: Final five-year results from the PE PROVE Study.
Topics: Cardiovascular Agents; Chromium; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Design; Registries; Risk Factors; Time Factors; Treatment Outcome | 2019 |
Clinical outcomes following implantation of the ION™ paclitaxel-eluting platinum chromium coronary stent in routine clinical practice: Results of the ION U.S. post-approval study.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Platinum; Product Surveillance, Postmarketing; Prospective Studies; Prosthesis Design; Registries; Time Factors; Treatment Outcome; United States | 2019 |
Small-vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus-eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post-Approval studies.
Topics: Aged; Cardiovascular Agents; Chromium; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Health Status Disparities; Humans; Male; Middle Aged; Minority Health; Myocardial Infarction; Observational Studies as Topic; Percutaneous Coronary Intervention; Platinum; Prosthesis Design; Race Factors; Registries; Retrospective Studies; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; United States | 2019 |
Assessment of strut coverage of everolimus-eluting platinum chromium stent 2 weeks after implantation by optical coherence tomography.
Topics: Absorbable Implants; Aged; Cardiovascular Agents; Chromium; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Japan; Male; Middle Aged; Neointima; Percutaneous Coronary Intervention; Platinum; Polyesters; Prospective Studies; Prosthesis Design; Tomography, Optical Coherence | 2019 |
Final 5-Year Results in Unselected Patients Implanted With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent (from the PROMUS Element Plus US Post-Approval Study).
Topics: Chromium; Combined Modality Therapy; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Platinum; Prospective Studies; Prosthesis Design; Time Factors; Treatment Outcome; United States | 2019 |
Longitudinal deformation of drug-eluting stents: evaluation by multislice computed tomography.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Cardiac Catheters; Chromium; Cobalt; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Endovascular Procedures; Equipment Design; Equipment Failure; Female; Humans; Male; Middle Aged; Multidetector Computed Tomography; Platinum; Retrospective Studies; Stainless Steel; Stress, Mechanical | 2014 |
Clinical and biomechanical behavior of a platinum-chromium stent platform in a large all-comer single-center population: insights from the Novara-PROMETEUS registry.
Topics: Aged; Angiography; Biomechanical Phenomena; Chromium; Coronary Artery Disease; Equipment Failure; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Registries; Retrospective Studies; Risk Factors; Stents | 2014 |
Small vessels and long lesions: changing label indications for drug eluting stents.
Topics: Cardiovascular Agents; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Percutaneous Coronary Intervention; Platinum; Sirolimus | 2015 |
Comparison of platinum chromium everolimus-eluting stent with cobalt chromium everolimus-eluting stent in unselected patients undergoing percutaneous coronary intervention.
Topics: Aged; Chromium; Cobalt; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Radiography; Treatment Outcome | 2015 |
Incidence and Clinical Impact of Stent Fracture After PROMUS Element Platinum Chromium Everolimus-Eluting Stent Implantation.
Topics: Aged; Aged, 80 and over; Cardiovascular Agents; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Humans; Incidence; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Percutaneous Coronary Intervention; Platinum; Prosthesis Design; Prosthesis Failure; Risk Factors; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional | 2015 |
One-Year Outcomes in "Real-World" Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent (from the PROMUS Element Plus US Post-Approval Study [PE-Plus PAS]).
Topics: Adult; Aged; Aged, 80 and over; Chromium; Coronary Angiography; Coronary Artery Disease; Device Approval; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Design; Registries; Sirolimus; Time Factors; Treatment Outcome; United States | 2016 |
Comparison of long-term clinical outcomes after the second-generation cobalt-chromium sirolimus-eluting stents implantation in diabetic versus non-diabetic patients: a subgroup analysis from the prospective FOCUS registry.
Topics: Aged; Chromium; Cobalt; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Sirolimus; Treatment Outcome | 2016 |
Effect on Clinical Restenosis of an Ultra-Thin-Strut Bare Metal Cobalt-Chromium Stent Versus a Thin-Strut Stainless Steel Stent.
Topics: Aged; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Stainless Steel; Stents; Treatment Outcome | 2016 |
Biodegradable polymer-based, argatroban-eluting, cobalt-chromium stent (JF-04) for treatment of native coronary lesions: final results of the first-in-man study and lessons learned.
Topics: Absorbable Implants; Adult; Aged; Aged, 80 and over; Arginine; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pipecolic Acids; Sulfonamides; Treatment Outcome | 2016 |
Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study.
Topics: Absorbable Implants; Acute Coronary Syndrome; Aged; Cardiovascular Agents; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Humans; Lactic Acid; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platinum; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Predictive Value of Tests; Prosthesis Design; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Wound Healing | 2017 |
Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus-eluting bioresorbable polylactide scaffold in comparison with the cobalt-chromium metallic stent?
Topics: Absorbable Implants; Cardiovascular Agents; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Sirolimus | 2017 |
Chromium status and glucose tolerance in Saudi men with and without coronary artery disease.
Topics: Adult; Aged; Blood Glucose; Case-Control Studies; Chromium; Coronary Artery Disease; Glucose Tolerance Test; Humans; Lipid Peroxides; Lipids; Male; Middle Aged; Myocardial Infarction; Risk Factors; Saudi Arabia | 2009 |
Optical coherence tomography assessment of early stent strut coverage in patients treated with a thin-strut bare cobalt-chromium stent coated with silicon carbide.
Topics: Aged; Carbon Compounds, Inorganic; Chromium; Cobalt; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Radiography; Silicon Compounds; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2012 |
Longitudinal compression of the platinum-chromium everolimus-eluting stent during coronary implantation: predisposing mechanical properties, incidence, and predictors in a large patient cohort.
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Chromium; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Equipment Failure Analysis; Everolimus; Female; Humans; Logistic Models; Male; Materials Testing; Middle Aged; Multivariate Analysis; Odds Ratio; Percutaneous Coronary Intervention; Platinum; Prosthesis Design; Prosthesis Failure; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Stress, Mechanical; Tomography, Optical Coherence; Treatment Outcome | 2013 |
Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Biocompatible Materials; Chromium; Cobalt; Coronary Artery Disease; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Registries; Stents; Time Factors; Treatment Outcome | 2007 |
Short-term effects of biocorrodible iron stents in porcine coronary arteries.
Topics: Animals; Biocompatible Materials; Chromium; Cobalt; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Fibrin; Inflammation; Iron Compounds; Stents; Swine | 2008 |